子宫内膜癌与正常子宫内膜组织中PR基因启动子区CpG岛甲基化的对比研究(2)
第1页 |
参见附件(2208KB,2页)。
参 考 文 献
[1] Gielen SC, Hanekamp EE, Hanifi,Moghaddam P, et al.Growth regulation and transeriptional activities of estrogen and Progesterone in human endometrial cancer cells.Int J Gyneeol Caneer, 2006,16(1):110,120.
[2] Dai D, Albita rL, Nguyen T, et al.A therapeutie model for advanced endometrial eancer: systemic progestin in combination with local adenoviral,mediated progesterone receptor expression. Mol Cancer Ther,2005,4(1):169,175.
[3] Miyamoto T, Watanabe J, Hata H, et al.Significance of progesterone receptor,A and ,B expressions in endometrial adenocarcinoma. J Steroid Biochem Mol Biol, 2004,92(3):111,118.
[4] 陈锐,于丽,廖秦平.子宫内膜癌中孕激素受体亚型表达及其甲基化状态的研究.现代妇产科进展,2008, 17(7):105,505.
[5] Sakaguchi H, Fujimoto J, Hong BL, et al. Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. Gynecol Oncol, 2004,93(2):394,399.
[6] Anatoliy A,Melnikov, Denise M,et al.Array,based multiplex analysis of DNA methylation in breast cancer tissues. Levenson J Mol Diagn,2008,10(1): 93,101.
您现在查看是摘要介绍页,详见PDF附件(2208KB,2页)。